$0.528700
0.024.93%
At Close: -
15 minutes delayed
NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-1.37 | $-1.23 | -11.4 % |
Mar 2024 | 2024-05-09 | $-4.90 | $-5.25 | 6.67 % |
Dec 2023 | 2024-03-26 | $-7.35 | $-10.50 | 30.0 % |
Sep 2023 | 2023-11-09 | $-12.95 | $-14.00 | 7.50 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $2.40M | $3.15M | -23.8 % |
Mar 2024 | 2024-05-09 | $2.63M | $3.28M | -19.8 % |
Dec 2023 | 2024-03-26 | $3.73M | $3.40M | 9.62 % |
Sep 2023 | 2023-11-09 | $3.27M | $3.55M | -8.03 % |
NovaBay Pharmaceuticals (NBY) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-1.37, which missed the estimate of $-1.23.
The Actual Revenue was $2.4M, which missed the estimate of $3.1M.
Browse earnings estimates, EPS, and revenue on all stocks.